Open Label Trial of Rapastinel (Formerly GLYX-13) in Individuals With Obsessive-Compulsive Disorder

NCT02267629 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

7

Enrollment

OTHER

Sponsor class

Conditions

Obsessive-Compulsive Disorder (OCD)

Interventions

DRUG: Rapastinel (formerly GLYX-13)

Sponsor

New York State Psychiatric Institute